Should a Second Transurethral Resection Be Performed in All Patients with T1 or High-Grade Non-Muscle-Invasive Bladder Cancer?

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F11%3A7069" target="_blank" >RIV/00064203:_____/11:7069 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11130/11:7069

Result on the web

<a href="http://www.sciencedirect.com/science/article/pii/S1569905611000297" target="_blank" >http://www.sciencedirect.com/science/article/pii/S1569905611000297</a>

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Should a Second Transurethral Resection Be Performed in All Patients with T1 or High-Grade Non-Muscle-Invasive Bladder Cancer?

Original language description

Context: Transurethral resection (TUR) is a critical step in the management of non-muscle-invasive bladder cancer (NMIBC). Because of the high risk of tumour persistence and understaging, the routine second TUR performed after 2-6 wk is recommended by European Association of Urology guidelines in all patients with T1 or high-grade NMIBC. Objective: To summarise arguments that support the recommendation of routine second TUR in all patients with T1 or high-grade NMIBC. Evidence acquisition: Data and arguments were retrieved from a critically selected list of articles and abstracts dealing with the surgical treatment of NMIBC. Evidence synthesis: In patients with T1 tumours, the risk of tumour persistence and tumour understaging detected by the second TUR was 33-78% and 2-28%, respectively. The pathologic finding achieved by second TUR can modify the treatment strategy in a significant number of patients. Correct staging in NMIBC enables the selection of the optimal treatment modality an

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FE - Other fields of internal medicine

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2011

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

European Urology Supplements

ISSN

1569-9056

e-ISSN

—

Volume of the periodical

10

Issue of the periodical within the volume

3

Country of publishing house

NL - THE KINGDOM OF THE NETHERLANDS

Number of pages

4

Pages from-to

"E8"-"E11"

UT code for WoS article

000290726700003

EID of the result in the Scopus database

—